{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T03:35:46Z","timestamp":1789875346448,"version":"4.0.1"},"reference-count":204,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Postgraduate Scientific Research Innovation Project of Hunan Province","award":["CX20230295"],"award-info":[{"award-number":["CX20230295"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82473530"],"award-info":[{"award-number":["82473530"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373488"],"award-info":[{"award-number":["82373488"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Natural Science Foundation of Hunan Province of China","award":["2024JJ4077"],"award-info":[{"award-number":["2024JJ4077"]}]},{"name":"the National Key R&D Program of China","award":["2021YFC2702004"],"award-info":[{"award-number":["2021YFC2702004"]}]},{"name":"the Key Program of Hunan Province Natural Science Foundation","award":["No.2025JJ30036"],"award-info":[{"award-number":["No.2025JJ30036"]}]},{"name":"Major Scientific Research Program for High-Level Health Personnel in Hunan Province Health and Family Planning Commission","award":["2023041"],"award-info":[{"award-number":["2023041"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"DOI":"10.1007\/s12016-026-09164-4","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:13:02Z","timestamp":1778458382000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["T-Cell Immunosenescence in Systemic Lupus Erythematosus: Molecular Mechanisms and Therapeutic Perspectives"],"prefix":"10.1007","volume":"69","author":[{"given":"Suqing","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lian","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanghan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,11]]},"reference":[{"key":"9164_CR1","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR (2024) Systemic lupus erythematosus: a review. JAMA 331:1480\u20131491. https:\/\/doi.org\/10.1001\/jama.2024.2315","journal-title":"JAMA"},{"key":"9164_CR2","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1038\/s41590-024-01898-7","volume":"25","author":"GC Tsokos","year":"2024","unstructured":"Tsokos GC (2024) The immunology of systemic lupus erythematosus. Nat Immunol 25:1332\u20131343. https:\/\/doi.org\/10.1038\/s41590-024-01898-7","journal-title":"Nat Immunol"},{"key":"9164_CR3","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41573-025-01242-0","volume":"24","author":"M Scherlinger","year":"2025","unstructured":"Scherlinger M, Kolios AGA, Kyttaris VC, Tsokos GC (2025) Advances in the treatment of systemic lupus erythematosus. Nat Rev Drug Discov 24:926\u2013944. https:\/\/doi.org\/10.1038\/s41573-025-01242-0","journal-title":"Nat Rev Drug Discov"},{"key":"9164_CR4","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nrrheum.2016.137","volume":"12","author":"EE Carter","year":"2016","unstructured":"Carter EE, Barr SG, Clarke AE (2016) The global burden of SLE: prevalence, health disparities and socioeconomic impact. Nat Rev Rheumatol 12:605\u2013620. https:\/\/doi.org\/10.1038\/nrrheum.2016.137","journal-title":"Nat Rev Rheumatol"},{"key":"9164_CR5","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41392-025-02168-0","volume":"10","author":"X Dai","year":"2025","unstructured":"Dai X, Fan Y, Zhao X (2025) Systemic lupus erythematosus: updated insights on the pathogenesis, diagnosis, prevention and therapeutics. Signal Transduct Target Ther 10:102. https:\/\/doi.org\/10.1038\/s41392-025-02168-0","journal-title":"Signal Transduct Target Ther"},{"key":"9164_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02371-z","volume":"10","author":"Y Fu","year":"2025","unstructured":"Fu Y et al (2025) Immunosenescence: signaling pathways, diseases and therapeutic targets. Signal Transduct Target Ther 10:250. https:\/\/doi.org\/10.1038\/s41392-025-02371-z","journal-title":"Signal Transduct Target Ther"},{"key":"9164_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01451-2","volume":"8","author":"Z Liu","year":"2023","unstructured":"Liu Z et al (2023) Immunosenescence: molecular mechanisms and diseases. Signal Transduct Target Ther 8:200. https:\/\/doi.org\/10.1038\/s41392-023-01451-2","journal-title":"Signal Transduct Target Ther"},{"key":"9164_CR8","doi-asserted-by":"publisher","unstructured":"Moysidou E et al (2022) Different types of chronic inflammation engender distinctive immunosenescent profiles in affected patients. Int J Mol Sci 23. https:\/\/doi.org\/10.3390\/ijms232314688","DOI":"10.3390\/ijms232314688"},{"key":"9164_CR9","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41577-019-0180-1","volume":"19","author":"JJ Goronzy","year":"2019","unstructured":"Goronzy JJ, Weyand CM (2019) Mechanisms underlying T cell ageing. Nat Rev Immunol 19:573\u2013583. https:\/\/doi.org\/10.1038\/s41577-019-0180-1","journal-title":"Nat Rev Immunol"},{"key":"9164_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103957","volume":"25","author":"Y Hu","year":"2026","unstructured":"Hu Y, He L, Long H (2026) Senescent CD4(+) T cells and autoimmune diseases: Mechanisms and therapeutic prospects. Autoimmun Rev 25:103957. https:\/\/doi.org\/10.1016\/j.autrev.2025.103957","journal-title":"Autoimmun Rev"},{"key":"9164_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01735-w","volume":"18","author":"Q Liu","year":"2025","unstructured":"Liu Q et al (2025) Immunosenescence and cancer: Molecular hallmarks, tumor microenvironment remodeling, and age-specific immunotherapy challenges. J Hematol Oncol 18:81. https:\/\/doi.org\/10.1186\/s13045-025-01735-w","journal-title":"J Hematol Oncol"},{"key":"9164_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40317-7","volume":"14","author":"W Yuan","year":"2023","unstructured":"Yuan W et al (2023) Modulating p38 MAPK signaling by proteostasis mechanisms supports tissue integrity during growth and aging. Nat Commun 14:4543. https:\/\/doi.org\/10.1038\/s41467-023-40317-7","journal-title":"Nat Commun"},{"key":"9164_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101422","volume":"71","author":"A Santoro","year":"2021","unstructured":"Santoro A, Bientinesi E, Monti D (2021) Immunosenescence and inflammaging in the aging process: Age-related diseases or longevity? Ageing Res Rev 71:101422. https:\/\/doi.org\/10.1016\/j.arr.2021.101422","journal-title":"Ageing Res Rev"},{"key":"9164_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2024.102540","volume":"101","author":"A Ajoolabady","year":"2024","unstructured":"Ajoolabady A et al (2024) Immunosenescence and inflammaging: Mechanisms and role in diseases. Ageing Res Rev 101:102540. https:\/\/doi.org\/10.1016\/j.arr.2024.102540","journal-title":"Ageing Res Rev"},{"key":"9164_CR15","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","volume":"908","author":"C Franceschi","year":"2000","unstructured":"Franceschi C et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 908:244\u2013254. https:\/\/doi.org\/10.1111\/j.1749-6632.2000.tb06651.x","journal-title":"Ann N Y Acad Sci"},{"key":"9164_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70515","volume":"6","author":"N Gong","year":"2025","unstructured":"Gong N et al (2025) Immunosenescence: molecular mechanisms, diseases, and therapeutic innovations. MedComm 6:e70515. https:\/\/doi.org\/10.1002\/mco2.70515","journal-title":"MedComm"},{"key":"9164_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01502-8","volume":"8","author":"X Li","year":"2023","unstructured":"Li X et al (2023) Inflammation and aging: Signaling pathways and intervention therapies. Signal Transduct Target Ther 8:239. https:\/\/doi.org\/10.1038\/s41392-023-01502-8","journal-title":"Signal Transduct Target Ther"},{"key":"9164_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.it.2009.04.007","volume":"30","author":"AC Maue","year":"2009","unstructured":"Maue AC et al (2009) T-cell immunosenescence: lessons learned from mouse models of aging. Trends Immunol 30:301\u2013305. https:\/\/doi.org\/10.1016\/j.it.2009.04.007","journal-title":"Trends Immunol"},{"key":"9164_CR19","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1189\/jlb.3RI0716-335R","volume":"102","author":"A Bektas","year":"2017","unstructured":"Bektas A, Schurman SH, Sen R, Ferrucci L (2017) Human T cell immunosenescence and inflammation in aging. J Leukoc Biol 102:977\u2013988. https:\/\/doi.org\/10.1189\/jlb.3RI0716-335R","journal-title":"J Leukoc Biol"},{"key":"9164_CR20","doi-asserted-by":"publisher","first-page":"6572","DOI":"10.4049\/jimmunol.162.11.6572","volume":"162","author":"AN Vallejo","year":"1999","unstructured":"Vallejo AN, Brandes JC, Weyand CM, Goronzy JJ (1999) Modulation of CD28 expression: distinct regulatory pathways during activation and replicative senescence. J Immunol 162:6572\u20136579","journal-title":"J Immunol"},{"key":"9164_CR21","doi-asserted-by":"publisher","first-page":"12182","DOI":"10.1128\/JVI.75.24.12182-12187.2001","volume":"75","author":"JJ Goronzy","year":"2001","unstructured":"Goronzy JJ et al (2001) Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 75:12182\u201312187. https:\/\/doi.org\/10.1128\/JVI.75.24.12182-12187.2001","journal-title":"J Virol"},{"key":"9164_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1177\/0961203320917749","volume":"29","author":"A Kosmaczewska","year":"2020","unstructured":"Kosmaczewska A et al (2020) CD4(+)CD28(null) T cells are expanded in moderately active systemic lupus erythematosus and secrete pro-inflammatory interferon gamma, depending on the Disease Activity Index. Lupus 29:705\u2013714. https:\/\/doi.org\/10.1177\/0961203320917749","journal-title":"Lupus"},{"key":"9164_CR23","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/0961203317722848","volume":"27","author":"S Piantoni","year":"2018","unstructured":"Piantoni S et al (2018) Effector T-cells are expanded in systemic lupus erythematosus patients with high disease activity and damage indexes. Lupus 27:143\u2013149. https:\/\/doi.org\/10.1177\/0961203317722848","journal-title":"Lupus"},{"key":"9164_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2022-000660","author":"S Yuan","year":"2022","unstructured":"Yuan S et al (2022) Phenotypical changes and clinical significance of CD4(+)\/CD8(+) T cells in SLE. Lupus Sci Med. https:\/\/doi.org\/10.1136\/lupus-2022-000660","journal-title":"Lupus Sci Med"},{"key":"9164_CR25","doi-asserted-by":"publisher","first-page":"292","DOI":"10.5114\/reum.2021.110318","volume":"59","author":"H Kalim","year":"2021","unstructured":"Kalim H, Wahono CS, Permana BPO, Pratama MZ, Handono K (2021) Association between senescence of T cells and disease activity in patients with systemic lupus erythematosus. Reumatologia 59:292\u2013301. https:\/\/doi.org\/10.5114\/reum.2021.110318","journal-title":"Reumatologia"},{"key":"9164_CR26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/nri3567","volume":"14","author":"DL Farber","year":"2014","unstructured":"Farber DL, Yudanin NA, Restifo NP (2014) Human memory T cells: generation, compartmentalization and homeostasis. Nat Rev Immunol 14:24\u201335. https:\/\/doi.org\/10.1038\/nri3567","journal-title":"Nat Rev Immunol"},{"key":"9164_CR27","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-2567.2010.03386.x","volume":"132","author":"V Libri","year":"2011","unstructured":"Libri V et al (2011) Cytomegalovirus infection induces the accumulation of short-lived, multifunctional CD4\u2009+\u2009CD45RA+CD27\u2009+\u2009T cells: the potential involvement of interleukin-7 in this process. Immunology 132:326\u2013339. https:\/\/doi.org\/10.1111\/j.1365-2567.2010.03386.x","journal-title":"Immunology"},{"key":"9164_CR28","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/imm.12409","volume":"144","author":"NE Riddell","year":"2015","unstructured":"Riddell NE et al (2015) Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults. Immunology 144:549\u2013560. https:\/\/doi.org\/10.1111\/imm.12409","journal-title":"Immunology"},{"key":"9164_CR29","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.4049\/jimmunol.161.2.1018","volume":"161","author":"M Schirmer","year":"1998","unstructured":"Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ (1998) Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4\u2009+\u2009CD28- T cells from rheumatoid arthritis patients. J Immunol 161:1018\u20131025","journal-title":"J Immunol"},{"key":"9164_CR30","doi-asserted-by":"publisher","first-page":"6301","DOI":"10.4049\/jimmunol.165.11.6301","volume":"165","author":"AN Vallejo","year":"2000","unstructured":"Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ (2000) Clonality and longevity of CD4\u2009+\u2009CD28null T cells are associated with defects in apoptotic pathways. J Immunol 165:6301\u20136307. https:\/\/doi.org\/10.4049\/jimmunol.165.11.6301","journal-title":"J Immunol"},{"key":"9164_CR31","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/s0047-6374(97)00161-9","volume":"102","author":"CM Weyand","year":"1998","unstructured":"Weyand CM, Brandes JC, Schmidt D, Fulbright JW, Goronzy JJ (1998) Functional properties of CD4\u2009+\u2009CD28- T cells in the aging immune system. Mech Ageing Dev 102:131\u2013147. https:\/\/doi.org\/10.1016\/s0047-6374(97)00161-9","journal-title":"Mech Ageing Dev"},{"key":"9164_CR32","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","volume":"191","author":"ZW Lai","year":"2013","unstructured":"Lai ZW et al (2013) Mechanistic target of Rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic Lupus erythematosus. J Immunol 191:2236\u20132246. https:\/\/doi.org\/10.4049\/jimmunol.1301005","journal-title":"J Immunol"},{"key":"9164_CR33","doi-asserted-by":"publisher","first-page":"6514","DOI":"10.4049\/jimmunol.179.10.6514","volume":"179","author":"M Thewissen","year":"2007","unstructured":"Thewissen M et al (2007) CD4\u2009+\u2009CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation. J Immunol 179:6514\u20136523. https:\/\/doi.org\/10.4049\/jimmunol.179.10.6514","journal-title":"J Immunol"},{"key":"9164_CR34","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.4049\/jimmunol.168.8.3839","volume":"168","author":"MR Snyder","year":"2002","unstructured":"Snyder MR et al (2002) Formation of the killer Ig-like receptor repertoire on CD4\u2009+\u2009CD28null T cells. J Immunol 168:3839\u20133846. https:\/\/doi.org\/10.4049\/jimmunol.168.8.3839","journal-title":"J Immunol"},{"key":"9164_CR35","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1172\/JCI42758","volume":"120","author":"KM Hertoghs","year":"2010","unstructured":"Hertoghs KM et al (2010) Molecular profiling of cytomegalovirus-induced human CD8\u2009+\u2009T cell differentiation. J Clin Invest 120:4077\u20134090. https:\/\/doi.org\/10.1172\/JCI42758","journal-title":"J Clin Invest"},{"key":"9164_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7692","volume":"6","author":"N Patsoukis","year":"2015","unstructured":"Patsoukis N et al (2015) PD-1 alters T-cell metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation. Nat Commun 6:6692. https:\/\/doi.org\/10.1038\/ncomms7692","journal-title":"Nat Commun"},{"key":"9164_CR37","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1158\/0008-5472.CAN-10-4158","volume":"71","author":"JL Yecies","year":"2011","unstructured":"Yecies JL, Manning BD (2011) Transcriptional control of cellular metabolism by mTOR signaling. Cancer Res 71:2815\u20132820. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4158","journal-title":"Cancer Res"},{"key":"9164_CR38","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1080\/08916934.2022.2112181","volume":"55","author":"DC Quintero-Gonzalez","year":"2022","unstructured":"Quintero-Gonzalez DC, Munoz-Urbano M, Vasquez G (2022) Mitochondria as a key player in systemic Lupus erythematosus. Autoimmunity 55:497\u2013505. https:\/\/doi.org\/10.1080\/08916934.2022.2112181","journal-title":"Autoimmunity"},{"key":"9164_CR39","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.4049\/jimmunol.1100978","volume":"187","author":"D Di Mitri","year":"2011","unstructured":"Di Mitri D et al (2011) Reversible senescence in human CD4\u2009+\u2009CD45RA+CD27- memory T cells. J Immunol 187:2093\u20132100. https:\/\/doi.org\/10.4049\/jimmunol.1100978","journal-title":"J Immunol"},{"key":"9164_CR40","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1038\/ni.2981","volume":"15","author":"A Lanna","year":"2014","unstructured":"Lanna A, Henson SM, Escors D, Akbar AN (2014) The kinase p38 activated by the metabolic regulator AMPK and scaffold Table 1 drives the senescence of human T cells. Nat Immunol 15:965\u2013972. https:\/\/doi.org\/10.1038\/ni.2981","journal-title":"Nat Immunol"},{"key":"9164_CR41","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1172\/JCI45785","volume":"122","author":"JS Tilstra","year":"2012","unstructured":"Tilstra JS et al (2012) NF-kappaB inhibition delays DNA damage-induced senescence and aging in mice. J Clin Invest 122:2601\u20132612. https:\/\/doi.org\/10.1172\/JCI45785","journal-title":"J Clin Invest"},{"key":"9164_CR42","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41423-025-01310-w","volume":"22","author":"H Mao","year":"2025","unstructured":"Mao H, Zhao X, Sun SC (2025) NF-kappaB in inflammation and cancer. Cell Mol Immunol 22:811\u2013839. https:\/\/doi.org\/10.1038\/s41423-025-01310-w","journal-title":"Cell Mol Immunol"},{"key":"9164_CR43","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ng.3040","volume":"46","author":"SE Flanagan","year":"2014","unstructured":"Flanagan SE et al (2014) Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat Genet 46:812\u2013814. https:\/\/doi.org\/10.1038\/ng.3040","journal-title":"Nat Genet"},{"key":"9164_CR44","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jaci.2024.09.020","volume":"155","author":"S Samra","year":"2025","unstructured":"Samra S, Bergerson JRE, Freeman AF, Turvey SE (2025) JAK-STAT signaling pathway, immunodeficiency, inflammation, immune dysregulation, and inborn errors of immunity. J Allergy Clin Immunol 155:357\u2013367. https:\/\/doi.org\/10.1016\/j.jaci.2024.09.020","journal-title":"J Allergy Clin Immunol"},{"key":"9164_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adk1643","volume":"9","author":"M Goto","year":"2024","unstructured":"Goto M et al (2024) Age-associated CD4(+) T cells with B cell-promoting functions are regulated by ZEB2 in autoimmunity. Sci Immunol 9:eadk1643. https:\/\/doi.org\/10.1126\/sciimmunol.adk1643","journal-title":"Sci Immunol"},{"key":"9164_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112973","volume":"142","author":"J Jiang","year":"2024","unstructured":"Jiang J, Yang M, Yang B, Wu H, Lu Q (2024) Elevated IL-15 levels in systemic lupus erythematosus: potential pathogenesis insight and therapeutic target. Int Immunopharmacol 142:112973. https:\/\/doi.org\/10.1016\/j.intimp.2024.112973","journal-title":"Int Immunopharmacol"},{"key":"9164_CR47","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202350603","volume":"54","author":"J Jiang","year":"2024","unstructured":"Jiang J et al (2024) CD4(+)CD57(+) senescent T cells as promoters of Systemic Lupus Erythematosus pathogenesis and the therapeutic potential of senolytic BCL-2 inhibitor. Eur J Immunol 54:e2350603. https:\/\/doi.org\/10.1002\/eji.202350603","journal-title":"Eur J Immunol"},{"key":"9164_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111373","volume":"40","author":"Y Fukushima","year":"2022","unstructured":"Fukushima Y et al (2022) Cis interaction of CD153 with TCR\/CD3 is crucial for the pathogenic activation of senescence-associated T cells. Cell Rep 40:111373. https:\/\/doi.org\/10.1016\/j.celrep.2022.111373","journal-title":"Cell Rep"},{"key":"9164_CR49","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.it.2009.03.013","volume":"30","author":"NP Weng","year":"2009","unstructured":"Weng NP, Akbar AN, Goronzy J (2009) CD28(-) T cells: their role in the age-associated decline of immune function. Trends Immunol 30:306\u2013312. https:\/\/doi.org\/10.1016\/j.it.2009.03.013","journal-title":"Trends Immunol"},{"key":"9164_CR50","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41590-021-00927-z","volume":"22","author":"M Mittelbrunn","year":"2021","unstructured":"Mittelbrunn M, Kroemer G (2021) Hallmarks of T cell aging. Nat Immunol 22:687\u2013698. https:\/\/doi.org\/10.1038\/s41590-021-00927-z","journal-title":"Nat Immunol"},{"key":"9164_CR51","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1097\/00007890-199711270-00025","volume":"64","author":"SC Eck","year":"1997","unstructured":"Eck SC, Chang D, Wells AD, Turka LA (1997) Differential down-regulation of CD28 by B7-1 and B7-2 engagement. Transplantation 64:1497\u20131499. https:\/\/doi.org\/10.1097\/00007890-199711270-00025","journal-title":"Transplantation"},{"key":"9164_CR52","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.molmed.2004.01.002","volume":"10","author":"AN Vallejo","year":"2004","unstructured":"Vallejo AN, Weyand CM, Goronzy JJ (2004) T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol Med 10:119\u2013124. https:\/\/doi.org\/10.1016\/j.molmed.2004.01.002","journal-title":"Trends Mol Med"},{"key":"9164_CR53","doi-asserted-by":"publisher","first-page":"46940","DOI":"10.1074\/jbc.M207352200","volume":"277","author":"AN Vallejo","year":"2002","unstructured":"Vallejo AN et al (2002) Molecular basis for the loss of CD28 expression in senescent T cells. J Biol Chem 277:46940\u201346949. https:\/\/doi.org\/10.1074\/jbc.M207352200","journal-title":"J Biol Chem"},{"key":"9164_CR54","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1111\/j.0105-2896.2005.00256.x","volume":"205","author":"AN Vallejo","year":"2005","unstructured":"Vallejo AN (2005) CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol Rev 205:158\u2013169. https:\/\/doi.org\/10.1111\/j.0105-2896.2005.00256.x","journal-title":"Immunol Rev"},{"key":"9164_CR55","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.4049\/jimmunol.0803449","volume":"182","author":"ST Parish","year":"2009","unstructured":"Parish ST, Wu JE, Effros RB (2009) Modulation of T lymphocyte replicative senescence via TNF-alpha inhibition: role of caspase-3. J Immunol 182:4237\u20134243. https:\/\/doi.org\/10.4049\/jimmunol.0803449","journal-title":"J Immunol"},{"key":"9164_CR56","doi-asserted-by":"publisher","first-page":"3543","DOI":"10.1182\/blood-2002-08-2574","volume":"101","author":"KJ Warrington","year":"2003","unstructured":"Warrington KJ, Vallejo AN, Weyand CM, Goronzy JJ (2003) CD28 loss in senescent CD4\u2009+\u2009T cells: reversal by interleukin-12 stimulation. Blood 101:3543\u20133549. https:\/\/doi.org\/10.1182\/blood-2002-08-2574","journal-title":"Blood"},{"key":"9164_CR57","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s10875-010-9449-7","volume":"30","author":"ST Parish","year":"2010","unstructured":"Parish ST, Wu JE, Effros RB (2010) Sustained CD28 expression delays multiple features of replicative senescence in human CD8 T lymphocytes. J Clin Immunol 30:798\u2013805. https:\/\/doi.org\/10.1007\/s10875-010-9449-7","journal-title":"J Clin Immunol"},{"key":"9164_CR58","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1084\/jem.20021288","volume":"198","author":"MS Topp","year":"2003","unstructured":"Topp MS et al (2003) Restoration of CD28 expression in CD28- CD8\u2009+\u2009memory effector T cells reconstitutes antigen-induced IL-2 production. J Exp Med 198:947\u2013955. https:\/\/doi.org\/10.1084\/jem.20021288","journal-title":"J Exp Med"},{"key":"9164_CR59","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1084\/jem.192.1.63","volume":"192","author":"V Appay","year":"2000","unstructured":"Appay V et al (2000) HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med 192:63\u201375. https:\/\/doi.org\/10.1084\/jem.192.1.63","journal-title":"J Exp Med"},{"key":"9164_CR60","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2004-11-4469","volume":"106","author":"PJ Dunne","year":"2005","unstructured":"Dunne PJ (2005) Quiescence and functional reprogramming of Epstein-Barr virus (EBV)-specific CD8\u2009+\u2009T cells during persistent infection. Blood 106:558\u2013565. https:\/\/doi.org\/10.1182\/blood-2004-11-4469","journal-title":"Blood"},{"key":"9164_CR61","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5025238","volume":"2018","author":"E Elkord","year":"2018","unstructured":"Elkord E, Sasidharan Nair V (2018) T-Regulatory cells in health and disease. J Immunol Res 2018:5025238. https:\/\/doi.org\/10.1155\/2018\/5025238","journal-title":"J Immunol Res"},{"key":"9164_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-02088-7","volume":"22","author":"X Yu","year":"2022","unstructured":"Yu X et al (2022) Distribution and clinical significance of circulating CD8(+)CD28(-) regulatory T cells in the peripheral blood of patients with pulmonary tuberculosis. BMC Pulm Med 22:291. https:\/\/doi.org\/10.1186\/s12890-022-02088-7","journal-title":"BMC Pulm Med"},{"key":"9164_CR63","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1016\/j.jaci.2017.08.021","volume":"141","author":"D Fenoglio","year":"2018","unstructured":"Fenoglio D et al (2018) CD8(+)CD28(-)CD127(lo)CD39(+) regulatory T-cell expansion: a new possible pathogenic mechanism for HIV infection? J Allergy Clin Immunol 141:2220-2233 e2224. https:\/\/doi.org\/10.1016\/j.jaci.2017.08.021","journal-title":"J Allergy Clin Immunol"},{"key":"9164_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20112810","author":"WX Huff","year":"2019","unstructured":"Huff WX, Kwon JH, Henriquez M, Fetcko K, Dey M (2019) The evolving role of CD8(+)CD28(-) immunosenescent T cells in cancer immunology. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20112810","journal-title":"Int J Mol Sci"},{"key":"9164_CR65","doi-asserted-by":"publisher","DOI":"10.1111\/acel.12675","author":"LA Callender","year":"2018","unstructured":"Callender LA et al (2018) Human CD8(+) EMRA T cells display a senescence-associated secretory phenotype regulated by p38 MAPK. Aging Cell. https:\/\/doi.org\/10.1111\/acel.12675","journal-title":"Aging Cell"},{"key":"9164_CR66","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nri2318","volume":"8","author":"J Nikolich-Zugich","year":"2008","unstructured":"Nikolich-Zugich J (2008) Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat Rev Immunol 8:512\u2013522. https:\/\/doi.org\/10.1038\/nri2318","journal-title":"Nat Rev Immunol"},{"key":"9164_CR67","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay3224","author":"JE Park","year":"2020","unstructured":"Park JE et al (2020) A cell atlas of human thymic development defines T cell repertoire formation. Science. https:\/\/doi.org\/10.1126\/science.aay3224","journal-title":"Science"},{"key":"9164_CR68","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1038\/s43587-025-00990-3","volume":"5","author":"Y Deng","year":"2025","unstructured":"Deng Y et al (2025) Single-cell analysis of human thymus and peripheral blood unveils the dynamics of T cell development and aging. Nat Aging 5:2494\u20132513. https:\/\/doi.org\/10.1038\/s43587-025-00990-3","journal-title":"Nat Aging"},{"key":"9164_CR69","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13671","volume":"21","author":"Z Liang","year":"2022","unstructured":"Liang Z, Dong X, Zhang Z, Zhang Q, Zhao Y (2022) Age-related thymic involution: mechanisms and functional impact. Aging Cell 21:e13671. https:\/\/doi.org\/10.1111\/acel.13671","journal-title":"Aging Cell"},{"key":"9164_CR70","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/j.it.2016.09.002","volume":"37","author":"AN Akbar","year":"2016","unstructured":"Akbar AN, Henson SM, Lanna A (2016) Senescence of T lymphocytes: implications for enhancing human immunity. Trends Immunol 37:866\u2013876. https:\/\/doi.org\/10.1016\/j.it.2016.09.002","journal-title":"Trends Immunol"},{"key":"9164_CR71","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1016\/j.coi.2009.05.012","volume":"21","author":"E Derhovanessian","year":"2009","unstructured":"Derhovanessian E, Larbi A, Pawelec G (2009) Biomarkers of human immunosenescence: impact of Cytomegalovirus infection. Curr Opin Immunol 21:440\u2013445. https:\/\/doi.org\/10.1016\/j.coi.2009.05.012","journal-title":"Curr Opin Immunol"},{"key":"9164_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101507","volume":"73","author":"J Lin","year":"2022","unstructured":"Lin J, Epel E (2022) Stress and telomere shortening: insights from cellular mechanisms. Ageing Res Rev 73:101507. https:\/\/doi.org\/10.1016\/j.arr.2021.101507","journal-title":"Ageing Res Rev"},{"key":"9164_CR73","doi-asserted-by":"publisher","DOI":"10.3390\/genes10040318","author":"Y Doksani","year":"2019","unstructured":"Doksani Y (2019) The response to DNA damage at telomeric repeats and its consequences for telomere function. Genes (Basel). https:\/\/doi.org\/10.3390\/genes10040318","journal-title":"Genes (Basel)"},{"key":"9164_CR74","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature02118","volume":"426","author":"F d'Adda di Fagagna","year":"2003","unstructured":"d\u2019Adda di Fagagna F et al (2003) A DNA damage checkpoint response in telomere-initiated senescence. Nature 426:194\u2013198. https:\/\/doi.org\/10.1038\/nature02118","journal-title":"Nature"},{"key":"9164_CR75","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1038\/s41556-022-00842-x","volume":"24","author":"F Rossiello","year":"2022","unstructured":"Rossiello F, Jurk D, Passos JF, d\u2019Adda di Fagagna F (2022) Telomere dysfunction in ageing and age-related diseases. Nat Cell Biol 24:135\u2013147. https:\/\/doi.org\/10.1038\/s41556-022-00842-x","journal-title":"Nat Cell Biol"},{"key":"9164_CR76","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1111\/imm.13410","volume":"164","author":"CH Fantecelle","year":"2021","unstructured":"Fantecelle CH et al (2021) Transcriptomic landscape of skin lesions in cutaneous Leishmaniasis reveals a strong CD8(+) T cell immunosenescence signature linked to immunopathology. Immunology 164:754\u2013765. https:\/\/doi.org\/10.1111\/imm.13410","journal-title":"Immunology"},{"key":"9164_CR77","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-018-0526-8","volume":"10","author":"L Prokopuk","year":"2018","unstructured":"Prokopuk L et al (2018) Loss of maternal EED results in postnatal overgrowth. Clin Epigenetics 10:95. https:\/\/doi.org\/10.1186\/s13148-018-0526-8","journal-title":"Clin Epigenetics"},{"key":"9164_CR78","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1038\/s43587-023-00462-6","volume":"3","author":"AT Lu","year":"2023","unstructured":"Lu AT et al (2023) Universal DNA methylation age across mammalian tissues. Nat Aging 3:1144\u20131166. https:\/\/doi.org\/10.1038\/s43587-023-00462-6","journal-title":"Nat Aging"},{"key":"9164_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102032","volume":"45","author":"NY Ngoi","year":"2021","unstructured":"Ngoi NY et al (2021) The redox-senescence axis and its therapeutic targeting. Redox Biol 45:102032. https:\/\/doi.org\/10.1016\/j.redox.2021.102032","journal-title":"Redox Biol"},{"key":"9164_CR80","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/nature07733","volume":"458","author":"M Diehn","year":"2009","unstructured":"Diehn M et al (2009) Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458:780\u2013783. https:\/\/doi.org\/10.1038\/nature07733","journal-title":"Nature"},{"key":"9164_CR81","doi-asserted-by":"publisher","first-page":"4004","DOI":"10.1172\/JCI75051","volume":"124","author":"SM Henson","year":"2014","unstructured":"Henson SM et al (2014) p38 signaling inhibits mTORC1-independent autophagy in senescent human CD8(+) T cells. J Clin Invest 124:4004\u20134016. https:\/\/doi.org\/10.1172\/JCI75051","journal-title":"J Clin Invest"},{"key":"9164_CR82","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1080\/08923973.2023.2232101","volume":"45","author":"F Asghari","year":"2023","unstructured":"Asghari F, Karimi MH, Pourfathollah AA (2023) mTORC1 inhibition may improve T lymphocytes affected by aging. Immunopharmacol Immunotoxicol 45:719\u2013729. https:\/\/doi.org\/10.1080\/08923973.2023.2232101","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"9164_CR83","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/s1074-7613(02)00323-0","volume":"16","author":"KA Frauwirth","year":"2002","unstructured":"Frauwirth KA et al (2002) The CD28 signaling pathway regulates glucose metabolism. Immunity 16:769\u2013777. https:\/\/doi.org\/10.1016\/s1074-7613(02)00323-0","journal-title":"Immunity"},{"key":"9164_CR84","doi-asserted-by":"publisher","DOI":"10.1111\/acel.70364","volume":"25","author":"L Kell","year":"2026","unstructured":"Kell L et al (2026) Rapamycin exerts its geroprotective effects in the ageing human immune system by enhancing resilience against DNA damage. Aging Cell 25:e70364. https:\/\/doi.org\/10.1111\/acel.70364","journal-title":"Aging Cell"},{"key":"9164_CR85","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1146\/annurev-immunol-020711-075024","volume":"30","author":"JD Powell","year":"2012","unstructured":"Powell JD, Pollizzi KN, Heikamp EB, Horton MR (2012) Regulation of immune responses by mTOR. Annu Rev Immunol 30:39\u201368. https:\/\/doi.org\/10.1146\/annurev-immunol-020711-075024","journal-title":"Annu Rev Immunol"},{"key":"9164_CR86","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/BOR.0000000000000687","volume":"32","author":"B Wyman","year":"2020","unstructured":"Wyman B, Perl A (2020) Metabolic pathways mediate pathogenesis and offer targets for treatment in rheumatic diseases. Curr Opin Rheumatol 32:184\u2013191. https:\/\/doi.org\/10.1097\/BOR.0000000000000687","journal-title":"Curr Opin Rheumatol"},{"key":"9164_CR87","doi-asserted-by":"publisher","first-page":"4319","DOI":"10.1073\/pnas.261702698","volume":"99","author":"BN Desai","year":"2002","unstructured":"Desai BN, Myers BR, Schreiber SL (2002) FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction. Proc Natl Acad Sci U S A 99:4319\u20134324. https:\/\/doi.org\/10.1073\/pnas.261702698","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9164_CR88","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ni.2005","volume":"12","author":"GM Delgoffe","year":"2011","unstructured":"Delgoffe GM et al (2011) The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2. Nat Immunol 12:295\u2013303. https:\/\/doi.org\/10.1038\/ni.2005","journal-title":"Nat Immunol"},{"key":"9164_CR89","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1189\/jlb.0705418","volume":"79","author":"O Kogkopoulou","year":"2006","unstructured":"Kogkopoulou O et al (2006) Conditional up-regulation of IL-2 production by p38 MAPK inactivation is mediated by increased Erk1\/2 activity. J Leukoc Biol 79:1052\u20131060. https:\/\/doi.org\/10.1189\/jlb.0705418","journal-title":"J Leukoc Biol"},{"key":"9164_CR90","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fimmu.2018.00065","volume":"9","author":"A Risco","year":"2018","unstructured":"Risco A, Martin-Serrano MA, Barber DF, Cuenda A (2018) p38gamma and p38delta are involved in T lymphocyte development. Front Immunol 9:65. https:\/\/doi.org\/10.3389\/fimmu.2018.00065","journal-title":"Front Immunol"},{"key":"9164_CR91","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1002\/eji.200535029","volume":"35","author":"F Dodeller","year":"2005","unstructured":"Dodeller F, Skapenko A, Kalden JR, Lipsky PE, Schulze-Koops H (2005) The p38 mitogen-activated protein kinase regulates effector functions of primary human CD4 T cells. Eur J Immunol 35:3631\u20133642. https:\/\/doi.org\/10.1002\/eji.200535029","journal-title":"Eur J Immunol"},{"key":"9164_CR92","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10753-011-9396-3","volume":"35","author":"L Zhi-Chun","year":"2012","unstructured":"Zhi-Chun L et al (2012) Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with Lupus nephritis. Inflammation 35:935\u2013943. https:\/\/doi.org\/10.1007\/s10753-011-9396-3","journal-title":"Inflammation"},{"key":"9164_CR93","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1002\/eji.201445312","volume":"45","author":"SM Henson","year":"2015","unstructured":"Henson SM, Macaulay R, Riddell NE, Nunn CJ, Akbar AN (2015) Blockade of PD-1 or p38 MAP kinase signaling enhances senescent human CD8(+) T-cell proliferation by distinct pathways. Eur J Immunol 45:1441\u20131451. https:\/\/doi.org\/10.1002\/eji.201445312","journal-title":"Eur J Immunol"},{"key":"9164_CR94","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1007\/s10875-009-9318-4","volume":"29","author":"CK Wong","year":"2009","unstructured":"Wong CK et al (2009) Activation profile of intracellular mitogen-activated protein kinases in peripheral lymphocytes of patients with systemic lupus erythematosus. J Clin Immunol 29:738\u2013746. https:\/\/doi.org\/10.1007\/s10875-009-9318-4","journal-title":"J Clin Immunol"},{"key":"9164_CR95","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.gendis.2020.06.005","volume":"8","author":"MR Zinatizadeh","year":"2021","unstructured":"Zinatizadeh MR et al (2021) The nuclear factor kappa B (NF-kB) signaling in cancer development and immune diseases. Genes Dis 8:287\u2013297. https:\/\/doi.org\/10.1016\/j.gendis.2020.06.005","journal-title":"Genes Dis"},{"key":"9164_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01468-7","volume":"8","author":"C Xue","year":"2023","unstructured":"Xue C et al (2023) Evolving cognition of the JAK-STAT signaling pathway: autoimmune disorders and cancer. Signal Transduct Target Ther 8:204. https:\/\/doi.org\/10.1038\/s41392-023-01468-7","journal-title":"Signal Transduct Target Ther"},{"key":"9164_CR97","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2567.2006.02429.x","volume":"119","author":"DL Wallace","year":"2006","unstructured":"Wallace DL et al (2006) Prolonged exposure of naive CD8\u2009+\u2009T cells to interleukin-7 or interleukin-15 stimulates proliferation without differentiation or loss of telomere length. Immunology 119:243\u2013253. https:\/\/doi.org\/10.1111\/j.1365-2567.2006.02429.x","journal-title":"Immunology"},{"key":"9164_CR98","doi-asserted-by":"publisher","first-page":"8218","DOI":"10.4049\/jimmunol.175.12.8218","volume":"175","author":"JM Fletcher","year":"2005","unstructured":"Fletcher JM et al (2005) Cytomegalovirus-specific CD4\u2009+\u2009T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol 175:8218\u20138225. https:\/\/doi.org\/10.4049\/jimmunol.175.12.8218","journal-title":"J Immunol"},{"key":"9164_CR99","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-024-00474-9","volume":"21","author":"F Xiong","year":"2024","unstructured":"Xiong F et al (2024) Quercetin ameliorates Lupus symptoms by promoting the apoptosis of senescent Tfh cells via the Bcl-2 pathway. Immun Ageing 21:69. https:\/\/doi.org\/10.1186\/s12979-024-00474-9","journal-title":"Immun Ageing"},{"key":"9164_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033939","volume":"7","author":"C Duftner","year":"2012","unstructured":"Duftner C et al (2012) Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4\u2009+\u2009CD28- T-cells. PLoS One 7:e33939. https:\/\/doi.org\/10.1371\/journal.pone.0033939","journal-title":"PLoS One"},{"key":"9164_CR101","doi-asserted-by":"publisher","first-page":"3070","DOI":"10.1172\/JCI39269","volume":"119","author":"D Sauce","year":"2009","unstructured":"Sauce D et al (2009) Evidence of premature immune aging in patients thymectomized during early childhood. J Clin Invest 119:3070\u20133078. https:\/\/doi.org\/10.1172\/JCI39269","journal-title":"J Clin Invest"},{"key":"9164_CR102","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.mad.2016.06.005","volume":"158","author":"C Soderberg-Naucler","year":"2016","unstructured":"Soderberg-Naucler C, Fornara O, Rahbar A (2016) Cytomegalovirus driven immunosenescence-an immune phenotype with or without clinical impact? Mech Ageing Dev 158:3\u201313. https:\/\/doi.org\/10.1016\/j.mad.2016.06.005","journal-title":"Mech Ageing Dev"},{"key":"9164_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2016.02111","volume":"7","author":"W Tu","year":"2016","unstructured":"Tu W, Rao S (2016) Mechanisms underlying T Cell immunosenescence: Aging and Cytomegalovirus infection. Front Microbiol 7:2111. https:\/\/doi.org\/10.3389\/fmicb.2016.02111","journal-title":"Front Microbiol"},{"key":"9164_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183357","volume":"12","author":"T Booiman","year":"2017","unstructured":"Booiman T et al (2017) Terminal differentiation of T cells is strongly associated with CMV infection and increased in HIV-positive individuals on ART and lifestyle matched controls. PLoS One 12:e0183357. https:\/\/doi.org\/10.1371\/journal.pone.0183357","journal-title":"PLoS One"},{"key":"9164_CR105","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/j.mad.2005.03.006","volume":"126","author":"FJ Plunkett","year":"2005","unstructured":"Plunkett FJ et al (2005) The impact of telomere erosion on memory CD8\u2009+\u2009T cells in patients with X-linked lymphoproliferative syndrome. Mech Ageing Dev 126:855\u2013865. https:\/\/doi.org\/10.1016\/j.mad.2005.03.006","journal-title":"Mech Ageing Dev"},{"key":"9164_CR106","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1182\/blood-2002-01-0160","volume":"100","author":"PJ Dunne","year":"2002","unstructured":"Dunne PJ et al (2002) Epstein-Barr virus-specific CD8(+) T cells that re-express CD45RA are apoptosis-resistant memory cells that retain replicative potential. Blood 100:933\u2013940. https:\/\/doi.org\/10.1182\/blood-2002-01-0160","journal-title":"Blood"},{"key":"9164_CR107","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1007\/s10753-023-01860-z","volume":"46","author":"T Wang","year":"2023","unstructured":"Wang T et al (2023) Coordinated priming of NKG2D pathway by IL-15 enhanced functional properties of cytotoxic CD4(+)CD28(-) T cells expanded in systemic lupus erythematosus. Inflammation 46:1587\u20131601. https:\/\/doi.org\/10.1007\/s10753-023-01860-z","journal-title":"Inflammation"},{"key":"9164_CR108","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.17119.1","author":"A Bano","year":"2019","unstructured":"Bano A et al (2019) CD28 (null) CD4 T-cell expansions in autoimmune disease suggest a link with cytomegalovirus infection. F1000Res. https:\/\/doi.org\/10.12688\/f1000research.17119.1","journal-title":"F1000Res"},{"key":"9164_CR109","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1177\/0961203315604910","volume":"25","author":"MF Ugarte-Gil","year":"2016","unstructured":"Ugarte-Gil MF et al (2016) Circulating CD4\u2009+\u2009CD28null and extra-thymic CD4\u2009+\u2009CD8+ double positive T cells are independently associated with disease damage in systemic lupus erythematosus patients. Lupus 25:233\u2013240. https:\/\/doi.org\/10.1177\/0961203315604910","journal-title":"Lupus"},{"key":"9164_CR110","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1177\/09612033261425742","volume":"35","author":"S Ranjan","year":"2026","unstructured":"Ranjan S, Dubey M, Panda AK (2026) Cytomegalovirus infection and its association with systemic lupus erythematosus: systematic review and meta-analysis. Lupus 35:446\u2013457. https:\/\/doi.org\/10.1177\/09612033261425742","journal-title":"Lupus"},{"key":"9164_CR111","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.reumae.2024.11.003","volume":"20","author":"I Etchegaray-Morales","year":"2024","unstructured":"Etchegaray-Morales I et al (2024) Epidemiology of systemic lupus erythematosus in Latin America. Reumatolog\u00eda Cl\u00ednica (English Edition) 20:560\u2013566. https:\/\/doi.org\/10.1016\/j.reumae.2024.11.003","journal-title":"Reumatolog\u00eda Cl\u00ednica (English Edition)"},{"key":"9164_CR112","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/rheumatology\/kead427","volume":"63","author":"C Lao","year":"2024","unstructured":"Lao C et al (2024) Mortality and causes of death in systemic lupus erythematosus in New Zealand: a population-based study. Rheumatology (Oxford) 63:1560\u20131567. https:\/\/doi.org\/10.1093\/rheumatology\/kead427","journal-title":"Rheumatology (Oxford)"},{"key":"9164_CR113","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1007\/s00296-023-05469-1","volume":"43","author":"M Arrucha-Cozaya","year":"2023","unstructured":"Arrucha-Cozaya M et al (2023) In-hospital mortality and associated factors in patients with systemic lupus erythematosus: analysis over more than 11 years in a reference hospital center. Rheumatol Int 43:2221\u20132231. https:\/\/doi.org\/10.1007\/s00296-023-05469-1","journal-title":"Rheumatol Int"},{"key":"9164_CR114","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1177\/0961203308089400","volume":"17","author":"A Tulunay","year":"2008","unstructured":"Tulunay A, Yavuz S, Direskeneli H, Eksioglu-Demiralp E (2008) CD8\u2009+\u2009CD28-, suppressive T cells in systemic lupus erythematosus. Lupus 17:630\u2013637. https:\/\/doi.org\/10.1177\/0961203308089400","journal-title":"Lupus"},{"key":"9164_CR115","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/08916930903374774","volume":"43","author":"A Perl","year":"2010","unstructured":"Perl A (2010) Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment. Autoimmunity 43:32\u201347. https:\/\/doi.org\/10.3109\/08916930903374774","journal-title":"Autoimmunity"},{"key":"9164_CR116","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/1058165","volume":"2016","author":"M Zabinska","year":"2016","unstructured":"Zabinska M, Krajewska M, Koscielska-Kasprzak K, Klinger M (2016) CD3(+)CD8(+)CD28(-) T lymphocytes in patients with Lupus Nephritis. J Immunol Res 2016:1058165. https:\/\/doi.org\/10.1155\/2016\/1058165","journal-title":"J Immunol Res"},{"key":"9164_CR117","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1189\/jlb.0506364","volume":"81","author":"L Zhao","year":"2007","unstructured":"Zhao L et al (2007) Changes of CD4\u2009+\u2009CD25+Foxp3\u2009+\u2009regulatory T cells in aged Balb\/c mice. J Leukoc Biol 81:1386\u20131394. https:\/\/doi.org\/10.1189\/jlb.0506364","journal-title":"J Leukoc Biol"},{"key":"9164_CR118","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe JP et al (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol 6:2853\u20132868. https:\/\/doi.org\/10.1371\/journal.pbio.0060301","journal-title":"PLoS Biol"},{"key":"9164_CR119","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaw8330","volume":"5","author":"Y Elyahu","year":"2019","unstructured":"Elyahu Y et al (2019) Aging promotes reorganization of the CD4 T cell landscape toward extreme regulatory and effector phenotypes. Sci Adv 5:eaaw8330. https:\/\/doi.org\/10.1126\/sciadv.aaw8330","journal-title":"Sci Adv"},{"key":"9164_CR120","doi-asserted-by":"publisher","first-page":"5725","DOI":"10.4049\/jimmunol.1500319","volume":"194","author":"S Tahir","year":"2015","unstructured":"Tahir S et al (2015) A CD153\u2009+\u2009CD4+ T follicular cell population with cell-senescence features plays a crucial role in lupus pathogenesis via osteopontin production. J Immunol 194:5725\u20135735. https:\/\/doi.org\/10.4049\/jimmunol.1500319","journal-title":"J Immunol"},{"key":"9164_CR121","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1146\/annurev-immunol-092419-031130","volume":"38","author":"MP Cancro","year":"2020","unstructured":"Cancro MP (2020) Age-associated B cells. Annu Rev Immunol 38:315\u2013340. https:\/\/doi.org\/10.1146\/annurev-immunol-092419-031130","journal-title":"Annu Rev Immunol"},{"key":"9164_CR122","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s10787-022-00932-0","volume":"30","author":"C Xu","year":"2022","unstructured":"Xu C, Wu Y, Liu N (2022) Osteopontin in autoimmune disorders: current knowledge and future perspective. Inflammopharmacology 30:385\u2013396. https:\/\/doi.org\/10.1007\/s10787-022-00932-0","journal-title":"Inflammopharmacology"},{"key":"9164_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/ar4150","volume":"15","author":"OJ Rullo","year":"2013","unstructured":"Rullo OJ et al (2013) Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosus. Arthritis Res Ther 15:R18. https:\/\/doi.org\/10.1186\/ar4150","journal-title":"Arthritis Res Ther"},{"key":"9164_CR124","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/802581","volume":"2011","author":"T Trivedi","year":"2011","unstructured":"Trivedi T et al (2011) Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J Biomed Biotechnol 2011:802581. https:\/\/doi.org\/10.1155\/2011\/802581","journal-title":"J Biomed Biotechnol"},{"key":"9164_CR125","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1126\/science.adf8531","volume":"383","author":"D Dai","year":"2024","unstructured":"Dai D et al (2024) The transcription factor ZEB2 drives the formation of age-associated B cells. Science 383:413\u2013421. https:\/\/doi.org\/10.1126\/science.adf8531","journal-title":"Science"},{"key":"9164_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103433","volume":"154","author":"QY Su","year":"2025","unstructured":"Su QY et al (2025) The role of age-associated B cells in systemic lupus erythematosus. J Autoimmun 154:103433. https:\/\/doi.org\/10.1016\/j.jaut.2025.103433","journal-title":"J Autoimmun"},{"key":"9164_CR127","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.593103","volume":"11","author":"S Iwata","year":"2020","unstructured":"Iwata S et al (2020) Enhanced fatty acid synthesis leads to subset imbalance and IFN-\u03b3 overproduction in t helper 1 cells. Front Immunol 11:593103. https:\/\/doi.org\/10.3389\/fimmu.2020.593103","journal-title":"Front Immunol"},{"key":"9164_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109202","volume":"248","author":"Y Lu","year":"2023","unstructured":"Lu Y et al (2023) T-cell senescence: a crucial player in autoimmune diseases. Clin Immunol 248:109202. https:\/\/doi.org\/10.1016\/j.clim.2022.109202","journal-title":"Clin Immunol"},{"key":"9164_CR129","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.1038\/s43587-025-00921-2","volume":"5","author":"HH Kim","year":"2025","unstructured":"Kim HH, Dixit VD (2025) Metabolic regulation of immunological aging. Nat Aging 5:1425\u20131440. https:\/\/doi.org\/10.1038\/s43587-025-00921-2","journal-title":"Nat Aging"},{"key":"9164_CR130","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1089\/ars.2013.5702","volume":"21","author":"E Doherty","year":"2014","unstructured":"Doherty E, Oaks Z, Perl A (2014) Increased mitochondrial electron transport chain activity at complex I is regulated by N-acetylcysteine in lymphocytes of patients with systemic lupus erythematosus. Antioxid Redox Signal 21:56\u201365. https:\/\/doi.org\/10.1089\/ars.2013.5702","journal-title":"Antioxid Redox Signal"},{"key":"9164_CR131","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1111\/cei.12256","volume":"176","author":"HT Lee","year":"2014","unstructured":"Lee HT, Lin CS, Lee CS, Tsai CY, Wei YH (2014) Increased 8-hydroxy-2\u2019-deoxyguanosine in plasma and decreased mRNA expression of human 8-oxoguanine DNA glycosylase 1, anti-oxidant enzymes, mitochondrial biogenesis-related proteins and glycolytic enzymes in leucocytes in patients with systemic lupus erythematosus. Clin Exp Immunol 176:66\u201377. https:\/\/doi.org\/10.1111\/cei.12256","journal-title":"Clin Exp Immunol"},{"key":"9164_CR132","doi-asserted-by":"publisher","DOI":"10.3390\/diseases12090226","author":"AV Poznyak","year":"2024","unstructured":"Poznyak AV et al (2024) Mitochondrial dysfunction in systemic lupus erythematosus: insights and therapeutic potential. Diseases. https:\/\/doi.org\/10.3390\/diseases12090226","journal-title":"Diseases"},{"key":"9164_CR133","doi-asserted-by":"publisher","first-page":"8853","DOI":"10.3390\/ijms13078853","volume":"13","author":"HT Lee","year":"2012","unstructured":"Lee HT et al (2012) Leukocyte mitochondrial DNA alteration in systemic lupus erythematosus and its relevance to the susceptibility to lupus nephritis. Int J Mol Sci 13:8853\u20138868. https:\/\/doi.org\/10.3390\/ijms13078853","journal-title":"Int J Mol Sci"},{"key":"9164_CR134","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1038\/s42255-023-00930-8","volume":"5","author":"A Picca","year":"2023","unstructured":"Picca A, Faitg J, Auwerx J, Ferrucci L, D\u2019Amico D (2023) Mitophagy in human health, ageing and disease. Nat Metab 5:2047\u20132061. https:\/\/doi.org\/10.1038\/s42255-023-00930-8","journal-title":"Nat Metab"},{"key":"9164_CR135","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1136\/annrheumdis-2013-203794","volume":"73","author":"TN Caza","year":"2014","unstructured":"Caza TN et al (2014) HRES-1\/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. Ann Rheum Dis 73:1888\u20131897. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203794","journal-title":"Ann Rheum Dis"},{"key":"9164_CR136","doi-asserted-by":"publisher","first-page":"3676","DOI":"10.4049\/jimmunol.173.6.3676","volume":"173","author":"G Nagy","year":"2004","unstructured":"Nagy G, Barcza M, Gonchoroff N, Phillips PE, Perl A (2004) Nitric oxide-dependent mitochondrial biogenesis generates Ca2\u2009+\u2009signaling profile of Lupus T cells. J Immunol 173:3676\u20133683. https:\/\/doi.org\/10.4049\/jimmunol.173.6.3676","journal-title":"J Immunol"},{"key":"9164_CR137","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1002\/1529-0131(200201)46:1<175::AID-ART10015>3.0.CO;2-H","volume":"46","author":"P Gergely Jr","year":"2002","unstructured":"Gergely P Jr. et al (2002) Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum 46:175\u2013190. https:\/\/doi.org\/10.1002\/1529-0131(200201)46:1%3C175::AID-ART10015%3E3.0.CO;2-H","journal-title":"Arthritis Rheum"},{"key":"9164_CR138","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163878","author":"CY Tsai","year":"2019","unstructured":"Tsai CY et al (2019) Molecular and cellular bases of immunosenescence, inflammation, and cardiovascular complications mimicking \u201cInflammaging\u201d in patients with systemic lupus erythematosus. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms20163878","journal-title":"Int J Mol Sci"},{"key":"9164_CR139","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.imlet.2007.04.013","volume":"111","author":"G Nagy","year":"2007","unstructured":"Nagy G, Clark JM, Buzas EI, Gorman CL, Cope AP (2007) Nitric oxide, chronic inflammation and autoimmunity. Immunol Lett 111:1\u20135. https:\/\/doi.org\/10.1016\/j.imlet.2007.04.013","journal-title":"Immunol Lett"},{"key":"9164_CR140","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1126\/science.1079368","volume":"299","author":"E Nisoli","year":"2003","unstructured":"Nisoli E et al (2003) Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299:896\u2013899. https:\/\/doi.org\/10.1126\/science.1079368","journal-title":"Science"},{"key":"9164_CR141","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.4049\/jimmunol.171.10.5188","volume":"171","author":"G Nagy","year":"2003","unstructured":"Nagy G, Koncz A, Perl A (2003) T cell activation-induced mitochondrial hyperpolarization is mediated by Ca2+- and redox-dependent production of nitric oxide. J Immunol 171:5188\u20135197. https:\/\/doi.org\/10.4049\/jimmunol.171.10.5188","journal-title":"J Immunol"},{"key":"9164_CR142","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","volume":"16","author":"A Sharabi","year":"2020","unstructured":"Sharabi A, Tsokos GC (2020) T cell metabolism: new insights in systemic Lupus erythematosus pathogenesis and therapy. Nat Rev Rheumatol 16:100\u2013112. https:\/\/doi.org\/10.1038\/s41584-019-0356-x","journal-title":"Nat Rev Rheumatol"},{"key":"9164_CR143","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116162","author":"M Halfon","year":"2024","unstructured":"Halfon M, Tankeu AT, Ribi C (2024) Mitochondrial dysfunction in systemic lupus erythematosus with a focus on Lupus Nephritis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms25116162","journal-title":"Int J Mol Sci"},{"key":"9164_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.929520","volume":"13","author":"L Zhao","year":"2022","unstructured":"Zhao L et al (2022) Mitochondrial impairment and repair in the pathogenesis of systemic Lupus erythematosus. Front Immunol 13:929520. https:\/\/doi.org\/10.3389\/fimmu.2022.929520","journal-title":"Front Immunol"},{"key":"9164_CR145","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/978-1-60761-720-4_4","volume":"900","author":"A Perl","year":"2012","unstructured":"Perl A, Hanczko R, Doherty E (2012) Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Methods Mol Biol 900:61\u201389. https:\/\/doi.org\/10.1007\/978-1-60761-720-4_4","journal-title":"Methods Mol Biol"},{"key":"9164_CR146","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.4049\/jimmunol.0803600","volume":"182","author":"DR Fernandez","year":"2009","unstructured":"Fernandez DR et al (2009) Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1\/Rab4-regulated lysosomal degradation. J Immunol 182:2063\u20132073. https:\/\/doi.org\/10.4049\/jimmunol.0803600","journal-title":"J Immunol"},{"key":"9164_CR147","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1177\/0961203314537697","volume":"23","author":"L Lopez-Lopez","year":"2014","unstructured":"Lopez-Lopez L et al (2014) Mitochondrial DNA damage is associated with damage accrual and disease duration in patients with systemic lupus erythematosus. Lupus 23:1133\u20131141. https:\/\/doi.org\/10.1177\/0961203314537697","journal-title":"Lupus"},{"key":"9164_CR148","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1189\/jlb.5HI0215-042R","volume":"99","author":"P Lopez","year":"2016","unstructured":"Lopez P, Rodriguez-Carrio J, Martinez-Zapico A, Caminal-Montero L, Suarez A (2016) Senescent profile of angiogenic T cells from systemic lupus erythematosus patients. J Leukoc Biol 99:405\u2013412. https:\/\/doi.org\/10.1189\/jlb.5HI0215-042R","journal-title":"J Leukoc Biol"},{"key":"9164_CR149","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.aax0860","volume":"368","author":"G Desdin-Mico","year":"2020","unstructured":"Desdin-Mico G et al (2020) T cells with dysfunctional mitochondria induce multimorbidity and premature senescence. Science 368:1371\u20131376. https:\/\/doi.org\/10.1126\/science.aax0860","journal-title":"Science"},{"key":"9164_CR150","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1002\/art.1780370219","volume":"37","author":"LM Warner","year":"1994","unstructured":"Warner LM, Adams LM, Sehgal SN (1994) Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus. Arthritis Rheum 37:289\u2013297. https:\/\/doi.org\/10.1002\/art.1780370219","journal-title":"Arthritis Rheum"},{"key":"9164_CR151","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1002\/art.22085","volume":"54","author":"D Fernandez","year":"2006","unstructured":"Fernandez D, Bonilla E, Mirza N, Niland B, Perl A (2006) Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. Arthritis Rheum 54:2983\u20132988. https:\/\/doi.org\/10.1002\/art.22085","journal-title":"Arthritis Rheum"},{"key":"9164_CR152","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/1756-185X.13816","volume":"23","author":"H Kalim","year":"2020","unstructured":"Kalim H et al (2020) Accelerated immune aging was correlated with lupus-associated brain fog in reproductive-age systemic lupus erythematosus patients. Int J Rheum Dis 23:620\u2013626. https:\/\/doi.org\/10.1111\/1756-185X.13816","journal-title":"Int J Rheum Dis"},{"key":"9164_CR153","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1177\/09612033211038057","volume":"30","author":"K Handono","year":"2021","unstructured":"Handono K, Wahono CS, Pratama MZ, Kalim H (2021) Association of the premature immunosenescence with the presence and severity of anemia among patients with systemic lupus erythematosus. Lupus 30:1906\u20131914. https:\/\/doi.org\/10.1177\/09612033211038057","journal-title":"Lupus"},{"key":"9164_CR154","doi-asserted-by":"publisher","first-page":"e15339","DOI":"10.1111\/1756-185X.15339","volume":"27","author":"MZ Pratama","year":"2024","unstructured":"Pratama MZ et al (2024) T-cell senescence was correlated with early atherosclerosis in patients with systemic lupus erythematosus. Int J Rheum Dis 27:e15339. https:\/\/doi.org\/10.1111\/1756-185X.15339","journal-title":"Int J Rheum Dis"},{"key":"9164_CR155","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.572876","volume":"11","author":"A Bortoluzzi","year":"2020","unstructured":"Bortoluzzi A et al (2020) The IMMENSE study: the interplay between iMMune and ENdothelial cells in mediating cardiovascular risk in systemic lupus erythematosus. Front Immunol 11:572876. https:\/\/doi.org\/10.3389\/fimmu.2020.572876","journal-title":"Front Immunol"},{"key":"9164_CR156","doi-asserted-by":"publisher","DOI":"10.3390\/jcm13071988","author":"FI Corona-Meraz","year":"2024","unstructured":"Corona-Meraz FI et al (2024) Biomarkers in systemic lupus erythematosus along with Metabolic Syndrome. J Clin Med. https:\/\/doi.org\/10.3390\/jcm13071988","journal-title":"J Clin Med"},{"key":"9164_CR157","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1038\/s43587-025-00981-4","volume":"5","author":"D Ezuz","year":"2025","unstructured":"Ezuz D et al (2025) Heme and iron toxicity in the aged spleen impairs T cell immunity through iron deprivation. Nat Aging 5:2247\u20132262. https:\/\/doi.org\/10.1038\/s43587-025-00981-4","journal-title":"Nat Aging"},{"key":"9164_CR158","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1024\/1661-8157\/a003443","volume":"109","author":"K Goehner Schweizer","year":"2020","unstructured":"Goehner Schweizer K, Maurer B (2020) New and established therapeutic options for the treatment of systemic lupus erythematosus. Praxis (Bern 1994) 109:341\u2013345. https:\/\/doi.org\/10.1024\/1661-8157\/a003443","journal-title":"Praxis (Bern 1994)"},{"key":"9164_CR159","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1007\/s00393-020-00771-w","volume":"79","author":"J Mucke","year":"2020","unstructured":"Mucke J, Dusing C, Chehab G, Schneider M (2020) [Treat to target in systemic lupus erythematosus]. Z Rheumatol 79:351\u2013358. https:\/\/doi.org\/10.1007\/s00393-020-00771-w","journal-title":"Z Rheumatol"},{"key":"9164_CR160","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/nrrheum.2013.157","volume":"10","author":"W Xiong","year":"2014","unstructured":"Xiong W, Lahita RG (2014) Pragmatic approaches to therapy for systemic lupus erythematosus. Nat Rev Rheumatol 10:97\u2013107. https:\/\/doi.org\/10.1038\/nrrheum.2013.157","journal-title":"Nat Rev Rheumatol"},{"key":"9164_CR161","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/ng1382","volume":"36","author":"DJ Baker","year":"2004","unstructured":"Baker DJ et al (2004) BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36:744\u2013749. https:\/\/doi.org\/10.1038\/ng1382","journal-title":"Nat Genet"},{"key":"9164_CR162","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13040723","author":"VJ Carpenter","year":"2021","unstructured":"Carpenter VJ, Saleh T, Gewirtz DA (2021) Senolytics for cancer therapy: is all that glitters really gold? Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13040723","journal-title":"Cancers (Basel)"},{"key":"9164_CR163","doi-asserted-by":"publisher","DOI":"10.3390\/biom15060860","author":"T Saliev","year":"2025","unstructured":"Saliev T, Singh PB (2025) Targeting senescence: a review of senolytics and senomorphics in anti-aging interventions. Biomolecules. https:\/\/doi.org\/10.3390\/biom15060860","journal-title":"Biomolecules"},{"key":"9164_CR164","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10571-025-01580-y","volume":"45","author":"C Gu","year":"2025","unstructured":"Gu C, Guo T, Chen X, Zhou X, Sun Y (2025) Senolytic treatment attenuates global ischemic brain injury and enhances cognitive recovery by targeting mitochondria. Cell Mol Neurobiol 45:60. https:\/\/doi.org\/10.1007\/s10571-025-01580-y","journal-title":"Cell Mol Neurobiol"},{"key":"9164_CR165","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1111\/joim.13141","volume":"288","author":"JL Kirkland","year":"2020","unstructured":"Kirkland JL, Tchkonia T (2020) Senolytic drugs: from discovery to translation. J Intern Med 288:518\u2013536. https:\/\/doi.org\/10.1111\/joim.13141","journal-title":"J Intern Med"},{"key":"9164_CR166","doi-asserted-by":"publisher","first-page":"955","DOI":"10.18632\/aging.101202","volume":"9","author":"Y Zhu","year":"2017","unstructured":"Zhu Y et al (2017) New agents that target senescent cells: the flavone, fisetin, and the BCL-X(L) inhibitors, A1331852 and A1155463. Aging (Albany NY) 9:955\u2013963. https:\/\/doi.org\/10.18632\/aging.101202","journal-title":"Aging (Albany NY)"},{"key":"9164_CR167","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ebiom.2018.09.015","volume":"36","author":"MJ Yousefzadeh","year":"2018","unstructured":"Yousefzadeh MJ et al (2018) Fisetin is a senotherapeutic that extends health and lifespan. EBioMedicine 36:18\u201328. https:\/\/doi.org\/10.1016\/j.ebiom.2018.09.015","journal-title":"EBioMedicine"},{"key":"9164_CR168","doi-asserted-by":"publisher","first-page":"995","DOI":"10.2174\/18715206113139990129","volume":"13","author":"DN Syed","year":"2013","unstructured":"Syed DN, Adhami VM, Khan MI, Mukhtar H (2013) Inhibition of Akt\/mTOR signaling by the dietary flavonoid fisetin. Anticancer Agents Med Chem 13:995\u20131001. https:\/\/doi.org\/10.2174\/18715206113139990129","journal-title":"Anticancer Agents Med Chem"},{"key":"9164_CR169","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960601","volume":"13","author":"S Ijima","year":"2022","unstructured":"Ijima S et al (2022) Fisetin reduces the senescent tubular epithelial cell burden and also inhibits proliferative fibroblasts in murine Lupus nephritis. Front Immunol 13:960601. https:\/\/doi.org\/10.3389\/fimmu.2022.960601","journal-title":"Front Immunol"},{"key":"9164_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2024.111995","volume":"222","author":"J Tavenier","year":"2024","unstructured":"Tavenier J et al (2024) Fisetin as a senotherapeutic agent: evidence and perspectives for age-related diseases. Mech Ageing Dev 222:111995. https:\/\/doi.org\/10.1016\/j.mad.2024.111995","journal-title":"Mech Ageing Dev"},{"key":"9164_CR171","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/acel.12445","volume":"15","author":"Y Zhu","year":"2016","unstructured":"Zhu Y et al (2016) Identification of a novel senolytic agent, navitoclax, targeting the Bcl-2 family of anti-apoptotic factors. Aging Cell 15:428\u2013435. https:\/\/doi.org\/10.1111\/acel.12445","journal-title":"Aging Cell"},{"key":"9164_CR172","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216965","volume":"594","author":"C Palominos","year":"2024","unstructured":"Palominos C et al (2024) Mitochondrial bioenergetics as a cell fate rheostat for responsive to Bcl-2 drugs: new cues for cancer chemotherapy. Cancer Lett 594:216965. https:\/\/doi.org\/10.1016\/j.canlet.2024.216965","journal-title":"Cancer Lett"},{"key":"9164_CR173","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.semcancer.2024.05.001","volume":"101","author":"Y Huang","year":"2024","unstructured":"Huang Y, Che X, Wang PW, Qu X (2024) p53\/MDM2 signaling pathway in aging, senescence and tumorigenesis. Semin Cancer Biol 101:44\u201357. https:\/\/doi.org\/10.1016\/j.semcancer.2024.05.001","journal-title":"Semin Cancer Biol"},{"key":"9164_CR174","doi-asserted-by":"publisher","DOI":"10.1152\/physiol.00003.2023","volume":"38","author":"S Aratani","year":"2023","unstructured":"Aratani S, Nakanishi M (2023) Recent advances in senolysis for age-related diseases. Physiology (Bethesda) 38:0. https:\/\/doi.org\/10.1152\/physiol.00003.2023","journal-title":"Physiology (Bethesda)"},{"key":"9164_CR175","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1146\/annurev-pharmtox-050120-105018","volume":"61","author":"PD Robbins","year":"2021","unstructured":"Robbins PD et al (2021) Senolytic drugs: reducing senescent cell viability to extend health span. Annu Rev Pharmacol Toxicol 61:779\u2013803. https:\/\/doi.org\/10.1146\/annurev-pharmtox-050120-105018","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"9164_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/cells13151292","author":"J Ya","year":"2024","unstructured":"Ya J, Bayraktutan U (2024) Senolytics and senomorphics targeting p38MAPK\/NF-\u03baB pathway protect endothelial cells from oxidative stress-mediated premature senescence. Cells. https:\/\/doi.org\/10.3390\/cells13151292","journal-title":"Cells"},{"key":"9164_CR177","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s40520-022-02190-0","volume":"34","author":"H Lin","year":"2022","unstructured":"Lin H, Salech F, Lim A, Vogrin S, Duque G (2022) The effect of rapamycin and its analogues on age-related musculoskeletal diseases: a systematic review. Aging Clin Exp Res 34:2317\u20132333. https:\/\/doi.org\/10.1007\/s40520-022-02190-0","journal-title":"Aging Clin Exp Res"},{"key":"9164_CR178","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1038\/s43587-024-00695-z","volume":"4","author":"S Gallage","year":"2024","unstructured":"Gallage S et al (2024) Ribosomal S6 kinase 1 regulates inflammaging via the senescence secretome. Nat Aging 4:1544\u20131561. https:\/\/doi.org\/10.1038\/s43587-024-00695-z","journal-title":"Nat Aging"},{"key":"9164_CR179","doi-asserted-by":"publisher","unstructured":"Politano D, Tonduti D, Battini R, Fazzi E, Orcesi S (2024) Exploring emerging JAK inhibitors in the treatment of Aicardi\u2013Gouti\u00e8res syndrome. Expert Opin Emerg Drugs (1):19. https:\/\/doi.org\/10.1080\/14728214.2024.2445508","DOI":"10.1080\/14728214.2024.2445508"},{"key":"9164_CR180","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/j.intimp.2011.04.015","volume":"11","author":"N Jin","year":"2011","unstructured":"Jin N et al (2011) The selective p38 mitogen-activated protein kinase inhibitor, SB203580, improves renal disease in MRL\/lpr mouse model of systemic lupus. Int Immunopharmacol 11:1319\u20131326. https:\/\/doi.org\/10.1016\/j.intimp.2011.04.015","journal-title":"Int Immunopharmacol"},{"key":"9164_CR181","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cei.12248","volume":"176","author":"H Patterson","year":"2014","unstructured":"Patterson H, Nibbs R, McInnes I, Siebert S (2014) Protein kinase inhibitors in the treatment of inflammatory and autoimmune diseases. Clin Exp Immunol 176:1\u201310. https:\/\/doi.org\/10.1111\/cei.12248","journal-title":"Clin Exp Immunol"},{"key":"9164_CR182","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2021.111526","volume":"197","author":"V Boccardi","year":"2021","unstructured":"Boccardi V, Mecocci P (2021) Senotherapeutics: targeting senescent cells for the main age-related diseases. Mech Ageing Dev 197:111526. https:\/\/doi.org\/10.1016\/j.mad.2021.111526","journal-title":"Mech Ageing Dev"},{"key":"9164_CR183","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1016\/S2666-7568(21)00300-7","volume":"3","author":"M Raffaele","year":"2022","unstructured":"Raffaele M, Vinciguerra M (2022) The costs and benefits of senotherapeutics for human health. Lancet Healthy Longev 3:e67\u2013e77. https:\/\/doi.org\/10.1016\/S2666-7568(21)00300-7","journal-title":"Lancet Healthy Longev"},{"key":"9164_CR184","doi-asserted-by":"publisher","first-page":"2554","DOI":"10.14336\/AD.2024.0206","volume":"15","author":"L Zheng","year":"2024","unstructured":"Zheng L et al (2024) Targeting cellular senescence in aging and age-related diseases: challenges, considerations, and the emerging role of senolytic and senomorphic therapies. Aging Dis 15:2554\u20132594. https:\/\/doi.org\/10.14336\/AD.2024.0206","journal-title":"Aging Dis"},{"key":"9164_CR185","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-025-09114-6","volume":"68","author":"A Matarneh","year":"2025","unstructured":"Matarneh A et al (2025) Chimeric antigen receptor T cell therapy in Systemic Lupus Erythematosus: mechanisms, clinical advances, and future directions a comprehensive review. Clin Rev Allergy Immunol 68:103. https:\/\/doi.org\/10.1007\/s12016-025-09114-6","journal-title":"Clin Rev Allergy Immunol"},{"key":"9164_CR186","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1662145","volume":"16","author":"G Li","year":"2025","unstructured":"Li G, Li D, Zhu X (2025) Next-generation T cell immunotherapy: overcoming exhaustion, senescence, and suppression. Front Immunol 16:1662145. https:\/\/doi.org\/10.3389\/fimmu.2025.1662145","journal-title":"Front Immunol"},{"key":"9164_CR187","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01518-8","volume":"21","author":"SW Wang","year":"2022","unstructured":"Wang SW et al (2022) Current applications and future perspective of CRISPR\/Cas9 gene editing in cancer. Mol Cancer 21:57. https:\/\/doi.org\/10.1186\/s12943-022-01518-8","journal-title":"Mol Cancer"},{"key":"9164_CR188","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/nrrheum.2009.180","volume":"5","author":"CM Weyand","year":"2009","unstructured":"Weyand CM, Fujii H, Shao L, Goronzy JJ (2009) Rejuvenating the immune system in rheumatoid arthritis. Nat Rev Rheumatol 5:583\u2013588. https:\/\/doi.org\/10.1038\/nrrheum.2009.180","journal-title":"Nat Rev Rheumatol"},{"key":"9164_CR189","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-025-07646-1","volume":"24","author":"M Fatahichegeni","year":"2025","unstructured":"Fatahichegeni M et al (2025) Immune effector cell-associated neurotoxicity syndrome following CAR T-cell therapy: a review of recent advances. J Transl Med 24:114. https:\/\/doi.org\/10.1186\/s12967-025-07646-1","journal-title":"J Transl Med"},{"key":"9164_CR190","doi-asserted-by":"publisher","first-page":"2430","DOI":"10.1182\/blood.2022017414","volume":"141","author":"MD Jain","year":"2023","unstructured":"Jain MD, Smith M, Shah NN (2023) How I treat refractory CRS and ICANS after CAR T-cell therapy. Blood 141:2430\u20132442. https:\/\/doi.org\/10.1182\/blood.2022017414","journal-title":"Blood"},{"key":"9164_CR191","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00134-024-07576-4","volume":"50","author":"T Schroeder","year":"2024","unstructured":"Schroeder T et al (2024) Management of chimeric antigen receptor T (CAR-T) cell-associated toxicities. Intensive Care Med 50:1459\u20131469. https:\/\/doi.org\/10.1007\/s00134-024-07576-4","journal-title":"Intensive Care Med"},{"key":"9164_CR192","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.07.003","volume":"493","author":"X Yuan","year":"2020","unstructured":"Yuan X, Dai M, Xu D (2020) TERT promoter mutations and GABP transcription factors in carcinogenesis: more foes than friends. Cancer Lett 493:1\u20139. https:\/\/doi.org\/10.1016\/j.canlet.2020.07.003","journal-title":"Cancer Lett"},{"key":"9164_CR193","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1002\/1878-0261.13802","volume":"19","author":"K Evangelou","year":"2025","unstructured":"Evangelou K, Gorgoulis VG (2025) Rejuvenating the immune system. Mol Oncol 19:584\u2013587. https:\/\/doi.org\/10.1002\/1878-0261.13802","journal-title":"Mol Oncol"},{"key":"9164_CR194","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adp3171","volume":"16","author":"JC Santamaria","year":"2024","unstructured":"Santamaria JC et al (2024) RANKL treatment restores thymic function and improves T cell-mediated immune responses in aged mice. Sci Transl Med 16:eadp3171. https:\/\/doi.org\/10.1126\/scitranslmed.adp3171","journal-title":"Sci Transl Med"},{"key":"9164_CR195","doi-asserted-by":"publisher","DOI":"10.1242\/dev.200995","author":"J Li","year":"2023","unstructured":"Li J, Wachsmuth LP, Xiao S, Condie BG, Manley NR (2023) Foxn1 overexpression promotes thymic epithelial progenitor cell proliferation and mTEC maintenance, but does not prevent thymic involution. Development. https:\/\/doi.org\/10.1242\/dev.200995","journal-title":"Development"},{"key":"9164_CR196","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1038\/s43587-024-00724-x","volume":"4","author":"H Jing","year":"2024","unstructured":"Jing H et al (2024) METTL3 governs thymocyte development and thymic involution by regulating ferroptosis. Nat Aging 4:1813\u20131827. https:\/\/doi.org\/10.1038\/s43587-024-00724-x","journal-title":"Nat Aging"},{"key":"9164_CR197","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1126\/science.adh4124","volume":"382","author":"ME Badr","year":"2023","unstructured":"Badr ME, Zhang Z, Tai X, Singer A (2023) CD8 T cell tolerance results from eviction of immature autoreactive cells from the thymus. Science 382:534\u2013541. https:\/\/doi.org\/10.1126\/science.adh4124","journal-title":"Science"},{"key":"9164_CR198","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/pin.13343","volume":"73","author":"Y Yamada","year":"2023","unstructured":"Yamada Y (2023) Histogenetic and disease-relevant phenotypes in thymic epithelial tumors (TETs): the potential significance for future TET classification. Pathol Int 73:265\u2013280. https:\/\/doi.org\/10.1111\/pin.13343","journal-title":"Pathol Int"},{"key":"9164_CR199","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.immuni.2015.01.006","volume":"42","author":"GJ Martinez","year":"2015","unstructured":"Martinez GJ et al (2015) The transcription factor NFAT promotes exhaustion of activated CD8(+) T cells. Immunity 42:265\u2013278. https:\/\/doi.org\/10.1016\/j.immuni.2015.01.006","journal-title":"Immunity"},{"key":"9164_CR200","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s12276-021-00568-0","volume":"53","author":"W Seo","year":"2021","unstructured":"Seo W, Jerin C, Nishikawa H (2021) Transcriptional regulatory network for the establishment of CD8(+) T cell exhaustion. Exp Mol Med 53:202\u2013209. https:\/\/doi.org\/10.1038\/s12276-021-00568-0","journal-title":"Exp Mol Med"},{"key":"9164_CR201","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1111\/j.1523-1755.2005.00461.x","volume":"68","author":"CC Mok","year":"2005","unstructured":"Mok CC, Tong KH, To CH, Siu YP, Au TC (2005) Tacrolimus for induction therapy of diffuse proliferative Lupus nephritis: an open-labeled pilot study. Kidney Int 68:813\u2013817. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00461.x","journal-title":"Kidney Int"},{"key":"9164_CR202","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/art.1780400106","volume":"40","author":"D Caccavo","year":"1997","unstructured":"Caccavo D et al (1997) Long-term treatment of systemic Lupus erythematosus with cyclosporin A. Arthritis Rheum 40:27\u201335. https:\/\/doi.org\/10.1002\/art.1780400106","journal-title":"Arthritis Rheum"},{"key":"9164_CR203","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keag125","author":"R Hazan","year":"2026","unstructured":"Hazan R, Tang Civilibal N, Baszis K, Bigley TM (2026) Single-center experience of voclosporin use for pediatric lupus nephritis: a case series. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keag125","journal-title":"Rheumatology"},{"key":"9164_CR204","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1177\/0961203309350320","volume":"19","author":"H Ogawa","year":"2010","unstructured":"Ogawa H, Kameda H, Amano K, Takeuchi T (2010) Efficacy and safety of cyclosporine A in patients with refractory systemic Lupus erythematosus in a daily clinical practice. Lupus 19:162\u2013169. https:\/\/doi.org\/10.1177\/0961203309350320","journal-title":"Lupus"}],"container-title":["Clinical Reviews in Allergy &amp; Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09164-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-026-09164-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-026-09164-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:13:05Z","timestamp":1778458385000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-026-09164-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,11]]},"references-count":204,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["9164"],"URL":"https:\/\/doi.org\/10.1007\/s12016-026-09164-4","relation":{},"ISSN":["1559-0267"],"issn-type":[{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,11]]},"assertion":[{"value":"22 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"43"}}